新型低温静脉输液装置治疗中枢性高热的临床效果

Abstract
Figure/Table
References
Related Citation (13)

Download: PDF (1397 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the efficacy and safety of a new type of cryogenic intravenous infusion device on patients with central hyperthermia.Methods The patients with central hyperthermia hospitalized in Characteristics Medical Center of Chinese People's Armed Police Force from January to October of 2022 were divided into instrumental group (35 cases) and control group (35 cases) by the willingness of patients or the families whether to use the new cryogenic intravenous infusion device or not. The control group was given routinely intravenous infusion of 4 ℃ liquid, while the instrumental group was given intravenous infusion of 4 ℃ liquid by the cryogenic intravenous infusion device. The patient's body temperature was dynamically monitored, and the cooling was stopped when the body temperature dropped to 38 ℃. The time required for the body temperature drop to 38 ℃, the cooling efficiency and the occurrence of adverse reactions between the two groups were compared.Results The time required for the body temperature drop to 38 ℃ in the control group (6.44±0.77 h) was significantly higher than that (4.47±0.84 h) in the instrumental group (P<0.05), and the effective cooling rate of the control group (57.14%) was also significantly lower than that (82.86%) of the instrumental group (P<0.05).The occurrence of adverse reactions in the instrumental group was 22.86%, which was significantly lower than 48.57% of the instrumental group (P<0.05).There was no significant difference of the incidences of arrhythmia, coagulation abnormality and skin frostbite between two groups, but the incidence of chills in the instrumental group was only 2.86%, which was significantly lower than 22.86% in the control group (P<0.05).Conclusions The new cryogenic intravenous infusion device is characterized by faster cooling speed, better efficiency, and less adverse reactions for patients with central hyperthermia.

Key words： central hyperthermia cryogenic intravenous infusion device physical cooling cooling effect

Received: 20 February 2023

ZTFLH:

R651.15

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	NIE Jing
	SUN Yan
	ZHONG Ruixia
	CHEN Huaying
	REN Jinhong

Cite this article:

NIE Jing,SUN Yan,ZHONG Ruixia等. Clinical therapeutic effect of a new cryogenic intravenous infusion device on patients with central hyperthermia[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(8): 648-651.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I8/648

[1]	Meier K, Lee K. Neurogenic Fever [J]. J Intensive Care Med, 2017, 32(2):124-129.
[2]	Ge X, Luan X. Uncontrolled central hyperthermia by standard dose of bromocriptine: a case report[J]. World J Clin Cases. 2020,8(23):6158-6163.
[3]	王黎平, 肖丽萍, 陈笑妹, 等. 不同介质冰袋冰敷对颅脑损伤高热患者降温效果的观察[J].护理学杂志, 2020, 35(15): 52-55.
[4]	Yokobori S, Koido Y, Shishido H, et al. Feasibility and safety of intravascular temperature management for severe heat stroke: a prospective multicenter pilot study[J]. Crit Care Med,2018,46(7):e670-e676.
[5]	Bartlett E S, Valenzuela T, Idris A, et al. Systematic review and meta-analysis of intravascular temperature management vs. surface cooling in comatose patients resuscitated from cardiac arrest[J]. Resuscitation, 2020,146:82-95.
[6]	Young P J, Prescott H C. When less is more in the active management of elevated body temperature of ICU patients[J]. Intensive Care Med,2019,45(9):1275-1278.
[7]	Ge X, Luan X. Uncontrolled central hyperthermia by standard dose of bromocriptine: a case report [J]. World J Clin Cases, 2020, 8(23):6158-6163.
[8]	Parker K C, Shelton R R, Lopez R M. Do alternative cooling methods have effective cooling rates for hyperthermia compared with previously established cwi cooling rates [J]. Sport Rehabil,2020,29(3):367-372.
[9]	Niven D J, Laupland K B. Pyrexia: aetiology in the ICU[J]. Crit Care, 2016, 20:247.
[10]	张云海, 吴丹, 邓梦华, 等. 一种新型低温静脉输液装置对中枢性高热患者的降温效果及安全性研究[J]. 中国全科医学, 2020,23(36):4656-4660.
[11]	Kliegel A, Janata A, Wandaller C, et al. Cold infusions alone are effective for induction of therapeutic hypothermia but do not keep patients cool after cardiac arrest [J]. Resuscitation, 2007, 73(1):46-53.
[12]	Yokobori S, Koido Y, Shishido H, et al. Feasibility and safety of intravascular temperature management for severe heat stroke: a prospective multicenter pilot study[J]. Crit Care Med, 2018, 46(7):e670-e676.
[13]	宫小慧.局部和全身降温治疗对重型颅脑损伤术后的应用效果分析[D].辽宁:大连医科大学,2016.
[14]	Keller E, Imhof H, Gasser S, et al.Endovascular cooling with heat exchange catheters: a new method to induce and maintain hypothermia [J]. Intensive Care Med, 2003, 29(6): 939-943.
[15]	Alne T. Therapeutic hypothermia: comparing surface vs intravascular cooling [J]. Dimens Crit Care Nurs, 2020, 39(1):12-22.
[16]	Dietrich W D, Bramlett H M. Therapeutic hypothermia and targeted temperature management in traumatic brain injury: clinical challenges for successful translation[J]. Brain Res,2016,1640:94-103.